Fact CheckerSign in

NCT05690009Completed

Real Clinical Practice Register of AlbUminuRia Detection in Patients With Previously undiAgnosed Chronic Kidney Disease

Source: ClinicalTrials.gov · Last updated 29 Aug 2024

Brief summary (registry, in English)

Real clinical practice register of Albuminuria detection in patients with previously undiagnosed chronic kidney disease

Status (registry)
Completed
Study type
Observational
Enrollment
4580 (actual)
First submitted
29 Dec 2022
Start date
27 Feb 2023
Primary completion date
23 Jan 2024
Lead sponsor
Eurasian Association of Therapists
NCT number
NCT05690009

What you commit to

  • Study type: Observational
  • Participants enrolled: 4580
  • From 27 Feb 2023 to the primary completion date, 23 Jan 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Diagnosis of diabetes mellitus (DM) type 1 or type 2 made before the screening for the register;

Other

  • Unwillingness of the patient to participate in the register;
  • Diagnosis of CKD made before the screening for the register;
  • Pregnancy;
  • Long distance running or very strenuous physical activity in the last 24 hours.

Who the study is looking for

  • Men and women aged 40 and older at the time of data entry;
  • A possibility to check for albuminuria using dipsticks and/or analysis for microalbuminuria or albumin-to-creatinine ratio in a single urine sample.

Age in the registry: 40 years to - · Sex: All

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Eurasian Association of Therapists
Coordinator of this site? Confirm its status
MoscowRussiaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.